We recently kicked off our new partnership with Filamentech (https://filamentech.com) by visiting their company President Dr. Srboljub Mijailovic in Boston. We are excited to help them develop their in silico platforms for early-stage drug discovery and clinical diagnostic tools.

The initial funding vehicle for this project will move through NIH seed funding (SBIR) to prepare for private investment.